Prurigo Nodularis Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working

 Breaking News
  • No posts were found

Prurigo Nodularis Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working

September 17
17:24 2021
Prurigo Nodularis Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working
DelveInsight Business Research LLP
DelveInsight’s ‘Prurigo nodularis (PN)—Market Insights, Epidemiology and Market Forecast–2030’ report deliver an in-depth understanding of the Prurigo nodularis (PN), historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

DelveInsight has launched a new report on “Prurigo Nodularis – Market Insights, Epidemiology, and Market Forecast-2030”.

DelveInsight’s “Prurigo Nodularis – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Prurigo Nodularis, historical and forecasted epidemiology as well as the Prurigo Nodularis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Prurigo Nodularis Market Report:

  1. The total diagnosed prevalent population of PN in the 7MM was found to be  550,036

  2. in 2020. 

  3. The United States had the largest share in the total diagnosed prevalent patient population in the 7MM, acquiring ~46.67% of the total cases in 2020. 

  4. Japan had 83,640 patients affected with PN in 2020, which is expected to increase in the forecast period (2020-2030).  

Key benefits of the report:

  1. Prurigo nodularis market report covers a descriptive overview and comprehensive insight of the Prurigo Nodularis Epidemiology and Prurigo Nodularis  market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

  2. The Prurigo Nodularis market report provides insights on the current and emerging therapies.

  3. Prurigo nodularis market report provides a global historical and forecasted market covering drug outreach in 7MM.

  4. The Prurigo Nodularis market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Prurigo Nodularis market.

Got queries? Click here to know more about the Prurigo Nodularis Market Landscape.

Prurigo Nodularis Overview

Prurigo nodularis (PN) is an intensely pruritic, chronic skin condition characterized by localized or generalized hyperkeratotic papules and nodules typically in a symmetrical distribution. PN is accompanied by long-standing pruritus and is thought to develop as a reaction to repeated scratching in patients with Chronic Prurigo (CP) from various etiologies, including dermatological, systemic, infectious, and psychiatric. 

Prurigo Nodularis Market 

The dynamics of the Prurigo Nodularis market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Menlo Therapeutics, Trevi Therapeutics, Galderma, Sanofi/ Regeneron, Amgen, Kiniksa Pharmaceuticals, Maruho, and others during the forecasted period 2018-2030.

Learn more by requesting for sample @ Prurigo Nodularis Market Landscape 

Prurigo Nodularis Pipeline Therapies and Key Companies 

  1. Serlopitant :Menlo Therapeutics

  2. Nalbuphine ER: Trevi Therapeutics

  3. Nemolizumab: Galderma 

  4. Sanofi/ Regeneron:Dupixent 

  5. Apremilast: Amagen

  6. KPL-716:Kiniksa Pharmaceuticals

  7. M118103:Maruho, and others

Prurigo Nodularis Market Drivers 

  1. Government Initiatives

  2. Pipeline Advancements and various off-label therapies

  3. Growth in Research and Development

  4. Increase in the number of patients

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Prurigo Nodularis Patient Share (%) Overview at a Glance

5. Prurigo Nodularis Market Overview at a Glance

6. Prurigo Nodularis Disease Background and Overview

7. Prurigo Nodularis Epidemiology and Patient Population

8. Country-Specific Patient Population of Prurigo Nodularis 

9. Prurigo Nodularis Current Treatment and Medical Practices

10. Unmet Needs

11. Prurigo Nodularis Emerging Therapies

12. Prurigo Nodularis Market Outlook

13. Country-Wise Prurigo Nodularis Market Analysis (2018–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Prurigo Nodularis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Click here to read more about Prurigo Nodularis Market Outlook 2030 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/